WSJ – FDA Grants Tentative Approval for Lilly and Boehringer Insulin

The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar(TM) (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.

Read more

Posted in Glucose & Insulin